Kolexia
Bielle Franck
Anatomie et cytologie
Hôpital Pitie Salpetriere
Paris, France
257 Activités
342 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Gliome Tumeurs du cerveau Glioblastome Méningiome Tumeurs du système nerveux central Épilepsie Tumeurs des méninges Récidive tumorale locale Sclérose

Industries

MSD
1 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Mismatch repair deficiency and Lynch syndrome among 1225 adult patients with glioma
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
Integrated proteogenomic characterization of glioblastoma evolution.
Cancer cell   01 janvier 2024
BRAIN METASTASIS OF A UROTHELIAL NEUROENDOCRINE CARCINOMA: A DOUBLE PITFALL FOR NEUROPATHOLOGISTS AND DNA-METHYLATION PROFILING.
Neuropathology and applied neurobiology   20 décembre 2023
Two novel tumours with NTRK2 fusion in the methylation class of extraventricular neurocytomas, including one intraventricular.
Brain pathology (Zurich, Switzerland)   23 novembre 2023
EXTH-59. IDENTIFICATION OF GROWTH HORMONE RECEPTOR AS A RELEVANT TARGET FOR PRECISION MEDICINE IN LOW-EGFR EXPRESSING GLIOBLASTOMA
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
CSIG-30. FUNCTIONAL CHARACTERISATION OF A NOVEL MUTATION IN PRKCA, THE MAJOR DRIVER OF CHORDOID GLIOMAS
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
EPCO-09. CHARACTERIZING THE GBM CELLULAR LANDSCAPE BY LARGE-SCALE SINGLE-NUCLEUS RNA-SEQUENCING
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
CTNI-33. TARGET TRIAL: A PHASE I/II OPEN-LABEL MULTICENTER STUDY TO ASSESS SAFETY, TOLERABILITY, AND CLINICAL EFFICACY OF AZD4547 IN PATIENTS WITH RELAPSED/REFRACTORY FGFR FUSION POSITIVE GLIOMA
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
DDDR-09. FUNCTIONAL GENOMICS AND CHEMOTHERAPY RESISTANCE SCREENING IDENTIFIES BIOMARKERS AND TARGETABLE MECHANISMS OF CCNU RESISTANCE IN GLIOMAS
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023
EPCO-37. DISSECTING GBM EVOLUTION FOLLOWING STANDARD-OF-CARE BY LARGE-SCALE LONGITUDINAL SINGLE NUCLEUS RNA-SEQUENCING
Abstracts from the 2023 Society for Neuro-Oncology’s 28th Annual Scientific Meeting and Education Day   10 novembre 2023